+
Site Tour

EuroPCR 2022: Expand your mitral portfolio with Tendyne™

A short expert interview with Alison Duncan and Lenard Conradi discussing Tendyne™ and how it can optimize patient outcomes and support the patient peri-procedurely.

Related Videos

EuroPCR 2022: Leading clinical evidence

EuroPCR 2022: Mitral replacement

PCRLV 2022: TAVI Hemodynamic performance

TAVI Summit - Drive TAVI to the next level

TAVI Case-Club – Alternative access

ESC 2021: Heart failure & vascular heart disease guidelines

Webinar: Aortic & Mitral Valve Disease

TAVI Summit 2023: Aortic stenosis

Navitor™: Voice of the Experts Federico de Marco

TAVI Summit 2023: Morphology

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

PCR LV 2021: Navitor™ Looking ahead

PCRLV 2022: bRIGHT 1 year

ESC 2022: FMR

PCRLV 2022: bRIGHT 30 days

CONNEXT


LIVE
RELATED EVENTS

Now you've got Navitor

MitraClip - AVVS 1 year 1 minute Mitral - Video

Echo course mitral TEER – procedural approach

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline